Population Health Investment, which is targeting therapeutics companies, plans to start trading today on the Nasdaq under PHICU. The offering covers 15 million shares priced at $10 per share. Read more.
Population Health Prices $150M IPO
Related Posts
Ventoux Amends $150M IPO Prospectus
The new SPAC is focused on businesses in North America within the hospitality, leisure, travel and dining sectors
Ares Acquisition Increases Funding while Lowering Valuation in X-Energy Deal
The SPAC lowered the pre-transaction equity value of the deal from $1.8 billion to $1.05 billion. This follows a downward adjustment made in June from the original $2.1 billion to $1.8 billion.
Hennessy Capital Investment V Stock & Warrants to Begin Separate Trading
The SPAC plans to target a U.S. company involved in sustainable industrial technology and or infrastructure, with an aggregate enterprise value of $1 billion or greater.
Monterey Bio Acquisition Files for $100M IPO
The SPAC is targeting the biotech industry.